[카테고리:] 블로그 (Blog)

In this article, we explore the key differences between Microarray and WES, highlighting their respective roles in diagnosing rare diseases and how they can complement each other for more comprehensive evaluations. Chromosomal Microarray Test Chromosomal Microarray Analysis (CMA) is a high-resolution genetic test used to detect copy number variations (CNVs), such as deletions or duplications,…

Exome sequencing (ES) has established itself as a pivotal tool in molecular diagnostics due to its cost-effectiveness and ability to identify pathogenic variants within coding exons, where approximately 80% of reported pathogenic variants reside. Despite its advantages, ES faces several limitations. Limitations of Standard Exome Sequencing For a more detailed exploration of the limitations of…

Informed consent has been officially around for over half a century with its first legal discussion beginning in 1905 and its establishment by law in 19571. Whether this sounds young or old, the advances and spread of modern medicine and research have undoubtedly made informed consent now a universal principle of medical and research ethics.…

How to Address Methodological Challenges in Rare Disease Research Researching rare diseases is challenging due to small patient populations, diverse symptoms, and limited existing data. These challenges can make understanding patient needs and developing effective treatments difficult. This article explores strategies to overcome these hurdles, improving research outcomes and patient care. Collaborative Research Networks One…

Hypertrophic cardiomyopathy (HCM) is a prevalent heart condition in South Korea, affecting about 1 in 300 people. This disease involves the thickening of the heart muscle, which can lead to heart failure and sudden cardiac death. Traditionally, mutations in sarcomere protein genes like MYBPC3 and MYH7 are linked to HCM. However, the ALPK3 gene, typically…

Diagnosing rare genetic diseases presents unique challenges due to the complexity and variability of symptoms. Accurate diagnosis is critical for effective treatment and management. Here are some best practices for medical staff to enhance the accuracy of diagnosing these conditions. 1. In-Depth Symptom Observation Thoroughly observing and documenting a patient’s symptoms is crucial. Detailed information…

Consanguineous marriages, or unions between closely related individuals, are common in certain cultures and regions, particularly in the Middle East and parts of South Asia. This tradition, while culturally significant, has notable implications for the prevalence of genetic disorders, including non syndromic hearing loss (NSHL), cystic fibrosis, thalassemia, and congenital disabilities. Genetic Implications of Consanguineous…

Today is February 29th, the Rare Disease Day. About 4% of the world’s population, around 300 million, suffer from rare diseases. However, due to a lack of social awareness, experts, and diagnostic and therapeutic skills, accurate diagnosis and treatment are rarely performed. Rare Disease Day, a global movement in solidarity with rare diseases, strives for…

What Should You Do If Your Patient Remains Undiagnosed After Exome Sequencing? Diagnosing patients with rare or undiagnosed conditions poses significant challenges for medical professionals. Medical professionals are left with many questions when initial genetic tests like Exome Sequencing (ES) do not yield precise results. This guide outlines three essential actions medical staff should take…

Next-generation sequencing has revolutionized genetic research by allowing for the rapid and cost-effective sequencing of entire genomes. This technological leap has not only facilitated initial gene discovery but also enabled continuous reanalysis of genetic data. The dynamic field of genetic medicine has greatly benefited from continuous reanalysis of genetic data, leading to the discovery of…